Background: The present study was undertaken to compare the effect of 100 mg intramuscular tramadol to 30 mg intramuscular Pentazocine for labour analgesia. Methods: A total of 60 cases with 37-40 weeks pregnancy in labour, without any foetal or maternal complications were selected. Out of them Inj. Tramadol was given to 30 cases while rest of the 30 patients received injection Pentazocine. Results: In Tramadol group pain relief was observed in 80% cases, effect started as early as 7-8 min and continued for 2.13 hrs. While in Pentazocine group pain relief was observed in only 60% cases with delayed onset (15-16 min), effect lasted for 2.67 hrs. Maternal and foetal complications were slightly more in Pentazocine group. Conclusions: Tramadol is an effective and safe labour analgesic, producing moderate to satisfactory. Besides it also significantly shortens the duration of labour. [Int J Reprod Contracept Obstet Gynecol 2013; 2(2.000): 186-189

Background: This study of last three years undertaken to determine the types of breast lumps as seen by an obstetrician and gynecologist and to determine the high risk factors for diagnosing malignant breast lump and guide patient for early and proper management. Methods: The diagnostic triad of clinical examination, FNAC and mammography was used to help detect a malignant mass. Results: Out of 202 cases, 162 were of benign breast lump and 40 of malignant breast lump. Age and family history were the most important risk factors. Other risk factors were nulliparity, first child after 30 years of age and postmenopausal age. Fibroadenoma was the most common benign tumor usually occurring at a younger age. Of the 40 cases of malignant breast lump, only 45% were detected early. Conclusion: All gynecologist should examine patient’s reproductive organs as well breast and also learn patient - how to examine breast herself regularly. Thus all obstetrician and gynecologist should participate in the breast cancer screening and help detect this malignancy in its early stage. [Int J Reprod Contracept Obstet Gynecol 2013; 2(3.000): 288-291